RE:RE:RBC 2020 Global Healthcare ConferenceI can not stress enough the importance of any investor,past present or future.
Please go & listen to the Oncoytics RBC Global health conference.
The "market" did like it.
Becuase as has been said, clear and laymans terms of what ONCs drug is all about.
He also hints about multiple-pharma finanical interests lately.
They have ample $ well into next year & do not need to draw down from the market.
Do not tak emy word for it, please listen for yourself.
The moderator Douglas Miehm is the anlaysts who has a outperfor/buy rating on ONC and a target price of $6.00 with a further upside of $18, should they meet addtional , not yet announced targets.
My guess, Doug M will be upgrading that price mid-eary June, once the abstracts and any new "deals" get announced.
JUST My OPIONION.... the $6.00 is something we will see next few weeks.